Jefferson University Hospitals

Provider Profile

Hie-Won L. Hann, MD, FAASLD

Hie-Won L. Hann, MD, FAASLD

Jefferson University Physician

Academic Title: Professor
Director, Liver Disease Prevention Center at Division of Gastroenterology and Hepatology

Gastroenterology - GI Cancer (Colon, Rectal, Liver, Bile Duct, Esophagus)
Gastroenterology - Liver Disease/Transplantation
Gastroenterology (Not Accepting New Patients)

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

132 S. 10th Street
Suite 480
Philadelphia PA 19107
Phone: (215) 955-8900
Fax: (215) 503-2527

Medical Services

Years in Practice


Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

Women in Leadership Award, Women's Way 1993

Fellow Koreans who made the Nation Proud Award, Korean Government 1995

Order of Civic Merit Award, Mokryon-Jang, President Kim Young Sam 1996

Distinguished Leadership Award, Hepatitis B Foundation 1999

Proud Medical Alumnus Award, Seoul National University 2001

Ham Choon Medical Science Award, Seoul National University College of 2001

A Distinguished Daughter of Pennsylvania 2003


Between 1971-1988, I have been a member (physician)of Clinical Research Division and the Co-Director of Liver Cancer Prevention Center, Fox Chase Cancer Center under the Direction of Dr. Baruch S. Blumberg, the 1976 Nobel Laureate for Discovery of Hepatitis B Virus. My goal is to provide the best care for patients with chronic hepatitis B and liver cancer utilizing the most updated therapy for hepatitis B virus infection to prevent liver cancer.

Personal Statement

To provide the best care possible for each of my patients using current treatment methods. I tailor my care to patients on an individualized basis. One on one contact between the doctor and patient is imperative to a successful healing relationship. This includes discussion of multiple factors that affect the patient's health and educating the patient about the illness. Improving the quality of life is my primary goal.


  • Seoul National University, Korea, Medical School


  • Seoul National University, Korea
  • Worcester City Hospital


  • Children's Hospital of Boston


  • Dana Farber Cancer Institute

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • CorVel
  • Geisinger Health Plan
  • HumanaChoicePPO,Medicare,GoldPlusHMO

Recent Publications

Persistent risk for hepatocellular carcinoma after more than a decade of successful hepatitis B virus suppression

Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients

Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study

Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection

The doylestown algorithm: A test to improve the performance of afp in the detection of hepatocellular carcinoma

Circulating Mitochondrial DNA Content Associated with the Risk of Liver Cirrhosis: A Nested Case–Control Study

Giving rituximab in patients with occult or resolved hepatitis B virus infection: Are the current guidelines good enough?

Giving rituximab in patients with occult or resolved hepatitis B virus infection: Are the current guidelines good enough?

Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection

A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation

Then and now: The progress in hepatitis B treatment over the past 20 years

Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy

HBV-related health behaviors in a socio-cultural context: Perspectives from Khmers and Koreans

Randomized comparison of Tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B

Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma

Correlates of Hepatitis B Virus Health-Related Behaviors of Korean Americans: A Situation-Specific Nursing Theory

Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV Patients

Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection - Results from a clinic-based longitudinal cohort

Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: A nested case-control analysis

Erratum: Recognition and management of HBV infection in a social context (Journal of Cancer Education DOI: 10.1007/s13187-011-0203-5)